Roles of programmed death‐1 and muscle innate lymphoid cell‐derived interleukin 13 in sepsis‐induced intensive care unit‐acquired weakness

• Ngā kaituhi matua: Yuichi Akama (Author), Eun Jeong Park (Author), Naoko Satoh‐Takayama (Author), Atsushi Ito (Author), Eiji Kawamoto (Author), Arong Gaowa (Author), Eri Matsuo (Author), Satoshi Oikawa (Author), Masafumi Saito (Author), Shigeaki Inoue (Author), Takayuki Akimoto (Author), Kei Suzuki (Author), Motomu Shimaoka (Author)
• Hōputu: Pukapuka
• I whakaputaina: Wiley, 2024-10-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Abstract Background Intensive care unit‐acquired weakness (ICU‐AW) is a syndrome characterized by a long‐term muscle weakness often observed in sepsis‐surviving patients during the chronic phase. Although ICU‐AW is independently associated with increased mortality, effective therapies have yet to be...